The move from the FDA marks the first tumor-agnostic approval of a HER2-directed therapy and antibody drug conjugate.
The US Food and Drug Administration has expanded the approval of fam-trastuzumab–deruxtecan-nxki to adults with unresectable or metastaticas well as adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma who had received a prior trastuzumab-based regimen.
The most common adverse reactions occurring in at least 20% of patients included decreased white blood cell count, hemoglobin, lymphocyte count, and neutrophil count, as well as nausea, fatigue, platelet count, vomiting, alopecia,Sharon Worcester, MA, is an award-winning medical journalist based in Birmingham, Alabama, writing for Medscape, MDedge and other affiliate sites. She currently covers oncology, but she has also written on a variety of other medical specialties and healthcare topics.
Malignant Breast Neoplasm Breast Carcinoma Biologic Therapy Biologics Toxicology Toxicity Poisoning Toxins Tumor Antineoplastic Drug Anti-Cancer Agents Erlotinib Gefitinib Imatinib Rituximab Su11248 Sunitinib Trastuzumab Noncolorectal Gastrointestinal Cancer Noncolorectal Gi Cancer Otolaryngology ENT Specialty Head And Neck Surgery ENT Speciality Dentistry
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA Expands Indications for Bempedoic Acid to Prevent Heart AttacksThe US Food and Drug Administration (FDA) has expanded the indications for bempedoic acid (Nexletol) and bempedoic acid plus ezetimibe combination (Nexlizet) to prevent heart attacks and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.
Les mer »
FDA Expands Indications for Bempedoic Acid in CVD PreventionBempedoic acid and bempedoic–ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.
Les mer »
FDA Expands Approval of Treatment for Generalized Pustular PsoriasisSpesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.
Les mer »
China's March factory activity expands for first time in six monthsChina's March factory activity expands for first time in six months
Les mer »
Neil Gaiman's Dead Boy Detectives is getting the Netflix treatmentAfter The Sandman, the streaming platform expands its Neil Gaiman universe with another adaptation in April
Les mer »
IXO™ 2024: South Korea's Largest Web3 Roadshow Expands LineupIXO™ 2024: South Korea's Largest Web3 Roadshow Expands Lineup
Les mer »